Navigation Links
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Date:8/19/2007

We will work with the FDA to address its comments and pursue the approval of bifeprunox as soon as possible."

"The development of bifeprunox offers the possibility of a new treatment approach for patients where maintaining stability is challenged by the metabolic consequences frequently encountered with long-term therapy. We continue to support the development of the compound and the approach," adds Gary L. Stiles, M.D., Executive Vice President and Chief Medical Officer, Wyeth Pharmaceuticals.

Bifeprunox, a partial dopamine agonist designed to normalize levels of chemical activity in the brain, has been studied in approximately 2,650 patients with schizophrenia at more than 200 Phase 2 and 3 clinical trial sites in the United States and throughout the world.

About Solvay Pharmaceuticals, Inc.

Solvay Pharmaceuticals, Inc., of Marietta, Georgia, is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit http://www.solvaypharmaceuticals-us.com.

Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardiometabolic, influenza vaccines, gastroenterology, and men's and women's health. Its 2006 sales were EUR 2.6 billion and it employs approximately 10,000 people worldwide. For more information, visit http://www.solvaypharmaceuticals.com.

SOLVAY is an international chemical and pharmaceutical Group with headquarters in Brussels. It employs some 30,000 people in 50 countries. In 2006 its consolidated sales amounted to EUR 9.4 billion generated by its three activity sectors: Chemicals, Plastics and Pharmaceuticals. SOLVAY (Euronext: SOLB.BE - Bloomberg: SOLB.BB - Reuters: SOLBt.BR) is listed on the Eur
'/>"/>

SOURCE Solvay Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
3. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
4. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
5. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013 The law firm of Rheingold, Valet, Rheingold, ... to be the first suit in New York ... user of two common anti-diabetic drugs, Byetta and Janumet (also ... resident Robert Cataletto , was filed on ... E.D.N.Y. CV 13-3411. Mr. Cataletto received prescriptions from ...
(Date:6/17/2013)... June 17, 2013   Southern Research Institute ... has been selected by its Board of Directors to ... July 8, 2013.   (Photo: http://photos.prnewswire.com/prnh/20130617/DC33167 ... Secrist, III, Ph.D., who served as president and CEO ... his retirement earlier this year after 34 years of ...
(Date:6/17/2013)... AVIV, Israel , June 17, 2013 ... the Board of Governors of the Israel-U.S. Binational Industrial ... million in funding for fourteen new projects between Israeli ... BIRD , the projects will access private sector ... approximately $33 million. The semi-annual meeting was held at ...
Breaking Medicine Technology:Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4
... 2011 Time is money, and time that is wasted looking ... A first-of-its-kind mobile and HTML5 app released by Providian Medical ... both time and money. With just a few quick and easy ... the optimum ultrasound machines based on their individual needs. The app ...
... SuccessEHS will sponsor the California Primary Care Association (CPCA) ... statewide leader and recognized voice representing the interests of ... CPCA represents more than 800 not-for-profit community clinics and ... SuccessEHS supports CPCA,s mission of eliminating ...
Cached Medicine Technology:Providian Medical Launches New Tool to Make Finding the Right Ultrasound Machine Easier Than Ever 2SuccessEHS Sponsors California Primary Care Association 2SuccessEHS Sponsors California Primary Care Association 3
(Date:6/17/2013)... BPI Sports , a leading ... Award at this year's GNC Franchise Convention held June ... is "Partner of the Year." This is the third ... 15 months, the other two being the 2011 "Rising ... BPI continues to pave the way for the sports ...
(Date:6/17/2013)... San Antonio, Texas (PRWEB) June 17, 2013 San ... newest location at 511 Dallas St. has just opened up a ... have been asking for a downtown optical shop over the years, ... optical shop brings SA Eye Center one step closer to providing ... addition to better access. The downtown optical shop is the ...
(Date:6/17/2013)... confronting childhood obesity, researchers at the Johns Hopkins ... approaches are important. A systematic review of childhood ... that incorporate schools and focus on both diet ... obesity in children. The results of the study ... , "In measuring the effectiveness of community-based programs ...
(Date:6/17/2013)... 17, 2013 Earlier this year, ... adopted tough standards to strengthen the privacy and ... Insurance Portability and Accountability Act (HIPAA) with the ... of the privacy of their health records and ... information, while also supporting the government’s ability to ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 The ... announce that they are now open in Schertz. ... neurofeedback treatments, counseling and access to educational support ... can be used to help with athletic performance, ... of the center, Cheryl Camarillo, LCSW, works primarily ...
Breaking Medicine News(10 mins):Health News:GNC Awards Another Prestigious Award to BPI Sports - 2012 Partner of the Year 2Health News:San Antonio Eye Center PA Opens New Optical Shop 2Health News:Community-based programs may help prevent childhood obesity 2Health News:Six Tips for Healthcare Providers About the New HIPAA Omnibus Rule 2Health News:Six Tips for Healthcare Providers About the New HIPAA Omnibus Rule 3Health News:Professional Center for Enhanced Performance Opens in Schertz 2
... modality in the treatment of coronary artery ... to bypass clogged arteries and damaged tissue. ... out for two important blood vessel growth factors, fibroblast ... (VEGF), have not yielded sterling outcomes. ...
... According to optometrist Dr. Ana Juricic there is an ... related macular degeneration. Not only that the situation// is ... people. She says that macular degeneration and cataracts ... age group. Dr. Juricic also advices her patients to ...
... On June 14th it was the World Blood Donor Day ... , Canadian Blood Services honored ... Organization (WHO) members, and more than 200 voluntary blood donor organizations, ... blood, plasma, platelets and bone marrow donation. Several clinics were organized ...
... flu with a 31-year-old man from south China's Guangdong Province ... ,The patient, surnamed Jiang, is a migrant worker in Shenzhen ... and has been hospitalised. He is now in critical condition, ... have found Jiang had been to a local market, where ...
... another eating disorder, it's just the name given to ... University of Glamorgan //says that muscle men are suffering ... from anorexia and bulimia. ,"Gym-goers are increasingly ... altered body images," he said. "Sufferers of negative or ...
... in New Zealand report low levels of perceived security ... according to a new survey//. ,The Youth 2000 ... Service and Auckland University, asked 922 Asian students about ... and school. ,Chinese and Indian students made ...
Cached Medicine News:Health News:Growth Factor Aids in Regeneration of Heart Blood Vessel 2Health News:AMD Found To Affect People In Their 50s 2Health News:Indian Students in New Zealand Feel Insecure 2
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... VH IVUS technology uses advanced spectral ... of ultrasound images and provide detailed ... patient's atherosclerotic plaques. The colorized VH ... fibrous, fibro-fatty, dense calcium, and necrotic ...
... Innova 2100IQ: See the finest vessels from ... devices. Its all enabled by the Revolution ... deliver excellent image quality and dose efficiency. ... installed worldwide, more physicians rely on these ...
... as Antidiurectic Hormone (ADH), is synthesized in ... flow to the posterior pituitary for storage ... by changes in blood osmolality and also ... blood volume or arterial pressure. Non-osmotic stimuli ...
Medicine Products: